These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15028596)

  • 1. Involvement of forebrain imidazoline and alpha(2)-adrenergic receptors in the antidipsogenic response to moxonidine.
    Andrade CA; Oliveira LB; Martinez G; Silva DC; De Luca LA; Menani JV
    Ann N Y Acad Sci; 2003 Dec; 1009():262-4. PubMed ID: 15028596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central moxonidine on water and NaCl intake.
    Menani JV; Sato MA; Haikel L; Vieira AA; de Andrade CA; da Silva DC; Renzi A; De Luca LA
    Brain Res Bull; 1999 Jul; 49(4):273-9. PubMed ID: 10424847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline and mixed alpha 2-adrenoceptor/imidazoline-receptor ligands: effects on sodium intake.
    Sugawara AM; Miguel TT; de Oliveira LB; Menani JV; De Luca Júnior LA
    Brain Res; 1999 Aug; 839(2):227-34. PubMed ID: 10519045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
    de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
    Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
    Urban R; Szabo B; Starke K
    Eur J Pharmacol; 1995 Aug; 282(1-3):19-28. PubMed ID: 7498275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxonidine and rilmenidine injected into the medial septal area reduces the salivation induced by pilocarpine.
    Saad WA; de Arruda Camargo LA; Simões S; Saad WA; Guarda RS; Guarda IF
    Auton Neurosci; 2004 May; 112(1-2):31-6. PubMed ID: 15233928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?
    Smyth DD; Penner SB
    J Auton Nerv Syst; 1998 Oct; 72(2-3):155-62. PubMed ID: 9851564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.
    Penner SB; Smyth DD
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():43-8. PubMed ID: 7915136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
    Khokhlova ON; Murashev AN; Medvedev OS
    Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
    Cao C; Kang CW; Kim SZ; Kim SH
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1996 Jan; 117(1):29-34. PubMed ID: 8825339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxonidine and central alpha2 adrenergic receptors in sodium intake.
    de Oliveira LB; De Luca LA; Menani JV
    Brain Res; 2003 Dec; 993(1-2):177-82. PubMed ID: 14642844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.
    Likungu J; Molderings GJ; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):689-92. PubMed ID: 8938671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.